Matches in Wikidata for { <http://www.wikidata.org/entity/Q74281523> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q74281523 description "clinical trial" @default.
- Q74281523 description "ensayu clínicu" @default.
- Q74281523 description "klinisch onderzoek" @default.
- Q74281523 description "клінічне випробування" @default.
- Q74281523 name "Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma" @default.
- Q74281523 name "Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma" @default.
- Q74281523 type Item @default.
- Q74281523 label "Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma" @default.
- Q74281523 label "Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma" @default.
- Q74281523 prefLabel "Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma" @default.
- Q74281523 prefLabel "Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma" @default.
- Q74281523 P1050 Q74281523-E4DE5255-F347-4A57-9A4B-A93466DC084B @default.
- Q74281523 P1132 Q74281523-B192F638-5AD3-45CC-A6A3-74599EF5B9D6 @default.
- Q74281523 P1476 Q74281523-96CF6238-B559-47B2-AD8E-938EFC7D585A @default.
- Q74281523 P2899 Q74281523-4ADB5EE0-4AFD-4792-B0F3-D9C94D6FE10D @default.
- Q74281523 P3098 Q74281523-8E445E2D-B41B-4BCE-9D6B-E850E8AE9C9B @default.
- Q74281523 P31 Q74281523-1038A987-C99F-4FA0-B003-B85E1A0273FA @default.
- Q74281523 P4135 Q74281523-69E2444E-393F-431A-9860-E27B84F6F6F5 @default.
- Q74281523 P4844 Q74281523-1C30D89F-796D-4B3C-A148-249A991F430F @default.
- Q74281523 P580 Q74281523-FCB95101-1A4F-4EEF-8E0E-37820DA09432 @default.
- Q74281523 P582 Q74281523-CC88287C-ED72-4F3E-AB44-48092F63A19C @default.
- Q74281523 P6099 Q74281523-9463EF5C-6DE5-4CDF-94F7-D17F3551D4BD @default.
- Q74281523 P8363 Q74281523-C3044FB2-2894-4A38-A330-C1A77F75183E @default.
- Q74281523 P859 Q74281523-2A75DFFD-3C53-4340-AE24-D598C904BF83 @default.
- Q74281523 P1050 Q180614 @default.
- Q74281523 P1132 "+43" @default.
- Q74281523 P1476 "Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma" @default.
- Q74281523 P2899 "+18" @default.
- Q74281523 P3098 "NCT04091217" @default.
- Q74281523 P31 Q30612 @default.
- Q74281523 P4135 "+75" @default.
- Q74281523 P4844 Q413299 @default.
- Q74281523 P580 "2019-10-24T00:00:00Z" @default.
- Q74281523 P582 "2021-04-26T00:00:00Z" @default.
- Q74281523 P6099 Q42824440 @default.
- Q74281523 P8363 Q78089383 @default.
- Q74281523 P859 Q212646 @default.